Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Public Health. 2001 May;91(5):774-80.

The impact of harm-reduction-based methadone treatment on mortality among heroin users.

Author information

1
Division of Public Health and Environment, Municipal Health Service, Nieuwe Achtergracht 100, 1018 WT Amsterdam, The Netherlands. mlangendam@gggd.amsterdam.nl

Abstract

OBJECTIVES:

The purpose of this study was to investigate the impact of harm-reduction-based methadone programs on mortality among heroin users.

METHODS:

A prospective cohort investigation was conducted among 827 participants in the Amsterdam Cohort Study. Poisson regression was used to identify methadone maintenance treatment characteristics (dosage, frequency of program attendance, and type of program) that are significantly and independently associated with mortality due to natural causes and overdose.

RESULTS:

From 1985 to 1996, 89 participants died of natural causes, and 31 died as a result of an overdose. After adjustment for HIV and underweight status, there was an increase in natural-cause mortality among subjects who left methadone treatment (relative risk [RR] = 2.38, 95% confidence interval [CI] = 1.28, 4.55). Leaving treatment was also related to higher overdose mortality, but only among injection drug users (RR = 4.55, 95% CI = 1.89, 10.00).

CONCLUSIONS:

Harm-reduction-based methadone treatment, in which the use of illicit drugs is tolerated, is strongly related to decreased mortality from natural causes and from overdoses. Provision of methadone in itself, together with social-medical care, appears more important than the actual methadone dosage.

PMID:
11344886
PMCID:
PMC1446673
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center